Skip to main content

Advertisement

Log in

Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff's clinical oncology. 5th ed. Philadelphia: Elsevier; 2014. p. 1373–96.

    Google Scholar 

  2. Eckel F, Brunner T, Jelic S. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016;27(supplement 5):v28–37. https://doi.org/10.1093/annonc/mdw324.

    Article  Google Scholar 

  3. NCCN Guidelines hepatobiliary cancers, version 2.2016.

  4. Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95(6):1402–10. https://doi.org/10.1111/j.1572-0241.2000.02070.x.

    Article  CAS  PubMed  Google Scholar 

  5. Shrikhande SV, Barreto SG, Singh S, Udwadia TE, Agarwal AK. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause. Eur J Surg Oncol. 2010;36(6):514–9. https://doi.org/10.1016/j.ejso.2010.05.002.

    Article  CAS  PubMed  Google Scholar 

  6. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109. https://doi.org/10.2147/CLEP.S37357.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer. 2007;96(6):896–902. https://doi.org/10.1038/sj.bjc.6603648.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. ABC-02 trial investigators cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81. https://doi.org/10.1056/NEJMoa0908721.

    Article  CAS  PubMed  Google Scholar 

  9. Yang R, Wang B, Chen YJ, et al. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a metanalysis. Anti-Cancer Drugs. 2013;24(8):871–7. https://doi.org/10.1097/CAD.0b013e3283637292.

    Article  CAS  PubMed  Google Scholar 

  10. Cho JY, Paik YH, Chang YS. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer. 2005;104(12):2753–8. https://doi.org/10.1002/cncr.21591.

    Article  CAS  PubMed  Google Scholar 

  11. Knox J, Hedley D, Oza A, et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. JCO. 2005;23(10):2332–8. https://doi.org/10.1200/JCO.2005.51.008.

    Article  CAS  Google Scholar 

  12. Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer. 2007;110(6):1307–12. https://doi.org/10.1002/cncr.22902.

    Article  CAS  PubMed  Google Scholar 

  13. Iqbal S, Rankin C, Lenz H, et al. A phase II trial of gemcitabine and capecitabine in patients with unressectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202. Cancer Chemother Pharmacol. 2011;68(6):1595–602. https://doi.org/10.1007/s00280-011-1657-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fiteni F, Nguyen T, Vernerey D, Paillard M, et al. Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. Cancer Med. 2014;3(6):1502–11. https://doi.org/10.1002/cam4.299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepato-Biliary-Pancreat Surg. 2007;14(4):351–7. https://doi.org/10.1007/s00534-006-1187-0.

    Article  Google Scholar 

  16. Kang MJ, Song Y, Jang J, et al. Role of radical surgery in patients with stage IV gallbladder cancer. HPB. 2012;14(12):805–11. https://doi.org/10.1111/j.1477-2574.2012.00544.x.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg. 2017;224(5):906–16. https://doi.org/10.1016/j.jamcollsurg.2016.12.058.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Castelo Branco.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Castelo Branco, M., Estevinho, F., Correia Pinto, J. et al. Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease. J Gastrointest Canc 50, 564–567 (2019). https://doi.org/10.1007/s12029-017-0044-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-0044-5

Keywords

Navigation